Month: April 2020

We are pleased to announce the successful recruitment of Garrett Nichols, MD, MS, as Chief Medical Officer for Istari Oncology, a privately held clinical-stage biotechnology company developing novel immunotherapies for the treatment of glioblastoma and a wide variety of solid tumors. The Company’s lead clinical stage asset is lerapolturev which has been designated by FDA as…